Insight

The COVID-19 experience for patients with CNS tumors

A collage photo of Amanda King and Terri Armstrong

Aug 6, 2024, 10:37

The COVID-19 experience for patients with CNS tumors

NCI Neuro-Oncology Branch shared a paper by Amanda King et. al on X, adding:

“A study led by Terri Armstrong and Amanda King of NCI Center for Cancer Research examined the COVID-19 experience for patients with CNS tumors.

These patients experienced higher levels of depression, which could negatively influence treatment success and survival.”

COVID-19

Source: NCI Neuro-Oncology Branch/X

The COVID-19 pandemic experience for patients with central nervous system tumors: Differences in patient-reported outcomes and practice recommendations.

Authors: Amanda King, Kayla N Roche, Elizabeth Vera, Valentina Pillai, Lily Polskin, Alvina A Acquaye, Lisa Boris, Eric Burton, Anna Choi, Ewa Grajkowska, Heather Leeper, Marissa Panzer, Marta Penas-Prado, Jennifer Reyes, Solmaz Sahebjam, Brett J Theeler, Jing Wu, Mark R Gilbert, and Terri S Armstrong.

COVID-19

Alvina A Acquaye Amanda King Anna Choi Brett J Theeler cancer CNS tumors COVID-19 Elizabeth Vera Eric Burton Ewa Grajkowska Heather Leeper Jennifer Reyes Jing Wu Kayla N Roche Lily Polskin Lisa Boris Marissa Panzer Mark R Gilbert Marta Penas-Prado NCI NCI Center for Cancer Research NCI Neuro-Oncology Branch OncoDaily Oncology Solmaz Sahebjam Terri Armstrong Terri S Armstrong Valentina Pillai

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage